Mar 13
|
Alcon to Host 2025 Capital Markets Day
|
Mar 13
|
Is it the Right Time to Hold Alcon Stock in Your Portfolio Now?
|
Feb 28
|
Alcon Stock Gains From Innovation Despite Macroeconomic Troubles
|
Feb 27
|
Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded Parameters
|
Feb 27
|
Alcon Inc (ALC) Full Year 2024 Earnings Call Highlights: Strong Financial Performance and ...
|
Feb 26
|
Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in Afterhours
|
Feb 26
|
Alcon (ALC) Reports Q4 Earnings: What Key Metrics Have to Say
|
Feb 25
|
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash Generation
|
Feb 24
|
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula Yet
|
Feb 19
|
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
|
Dec 31
|
Alcon to Present at 2025 Annual J.P. Morgan Healthcare Conference
|
Sep 24
|
Reasons to Retain Alcon Stock in Your Portfolio for Now
|
Jun 25
|
Are Options Traders Betting on a Big Move in Alcon (ALC) Stock?
|
Jun 24
|
Alcon (ALC) Achieves FDA 510(k) Clearance for Unity VCS and Unity CS
|
Jun 24
|
Alcon obtains FDA 510(k) approval for Unity VCS and CS systems
|
Jun 24
|
Alcon’s Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance
|
May 30
|
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board
|
May 23
|
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?
|
May 23
|
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
|
May 23
|
Do Options Traders Know Something About Alcon (ALC) Stock We Don't?
|